NEWS

Vevo Therapeutics to Open Source Milestone Tahoe-100M Dataset
Vevo Therapeutics to Open Source Milestone Tahoe-100M Dataset 01/13/2025
Alessa Therapeutics Announces First Patient Enrolled in the Enolen Study for Localized Drug Delivery for Prostate Cancer
Alessa Therapeutics Announces First Patient Enrolled in the Enolen Study for Localized Drug Delivery for Prostate Cancer 01/10/2025
Sana’s cell therapy may be ‘transformative cure’ for type 1 diabetes: analysts
Sana’s cell therapy may be ‘transformative cure’ for type 1 diabetes: analysts 01/10/2025
Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in Chronic Obstructive Pulmonary Disease
Aer Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Fexlamose in Chronic Obstructive Pulmonary Disease 01/09/2025
ScaleReady awards a G-Rex® Grant to Moonlight Bio
ScaleReady awards a G-Rex® Grant to Moonlight Bio 12/20/2024
Alessa Therapeutics Announces Closing $15M Seed Financing
Alessa Therapeutics Announces Closing $15M Seed Financing 12/16/2024
UCSF Congratulates Professor Pamela M. England, PhD, and her spinout company, 153 Therapeutics.
UCSF Congratulates Professor Pamela M. England, PhD, and her spinout company, 153 Therapeutics. 12/12/2024
Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines
Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines 12/12/2024
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery 12/10/2024
Delve Bio Announces Launch of its Groundbreaking Genomic Infectious Disease Test, Delve Detect
Delve Bio Announces Launch of its Groundbreaking Genomic Infectious Disease Test, Delve Detect 12/04/2024
Exai Bio Announces Publication in Nature Communications Highlighting its Generative AI Liquid Biopsy Platform
Exai Bio Announces Publication in Nature Communications Highlighting its Generative AI Liquid Biopsy Platform 11/22/2024
UCSF Joins I-Corps’ New Regional Innovation Hub for the Northwest
UCSF Joins I-Corps’ New Regional Innovation Hub for the Northwest 11/19/2024
Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections
Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections 11/13/2024
Enlaza Therapeutics marries covalent and biologic drugs
Enlaza Therapeutics marries covalent and biologic drugs 11/12/2024
Female Founders Social Event
Female Founders Social Event 11/07/2024